Cidofovir · more major-labeled pairs than Bictegravir

SPL labels Bictegravir + Cidofovir as minor; Bictegravir 16 / Cidofovir 11 in that band.

Mechanism on file: Both drugs are removed from the body through the same pathway in the kidneys. Taking them together may cause the drugs to build up in your system.

FDA SPL severity: Minor

Bictegravir

Full Bictegravir label record

Integrase Inhibitor / NRTI Combination

Cidofovir

Full Cidofovir label record

Antiviral (Nucleotide Analog)

Bictegravir + Cidofovir · SPL mechanism field

Both drugs are removed from the body through the same pathway in the kidneys. Taking them together may cause the drugs to build up in your system.

Minor band excerpt · Bictegravir with Cidofovir

Some examples of drugs that are eliminated by active tubular secretion include, but are not limited to, acyclovir, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs [see Warnings and Precautions (5.4) ] .

Bictegravir · 19 SPL pairs (broader portfolio than Cidofovir)

View all Bictegravir interactions →

Cidofovir · 5 major-labeled pairs (vs Bictegravir's 2)

View all Cidofovir interactions →

FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.